DXJS | HEWJ | DXJS / HEWJ | |
Gain YTD | -3.181 | -1.994 | 160% |
Net Assets | 70.1M | 358M | 20% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 46.00 | 29.00 | 159% |
Yield | 2.44 | 1.68 | 145% |
Fund Existence | 12 years | 11 years | - |
DXJS | HEWJ | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 11 days ago60% | 11 days ago74% |
Momentum ODDS (%) | 11 days ago90% | 11 days ago85% |
MACD ODDS (%) | 11 days ago60% | 11 days ago90% |
TrendWeek ODDS (%) | 11 days ago66% | 11 days ago85% |
TrendMonth ODDS (%) | 11 days ago84% | 11 days ago82% |
Advances ODDS (%) | 23 days ago81% | 12 days ago81% |
Declines ODDS (%) | 11 days ago65% | N/A |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 11 days ago87% | 11 days ago80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
KSOCX | 177.53 | 1.77 | +1.01% |
Kinetics Small Cap Opportunities Adv C | |||
VYMRX | 17.11 | 0.07 | +0.41% |
Voya Mid Cap Research Enhanced Index C | |||
EILIX | 12.07 | 0.04 | +0.33% |
Eaton Vance International Small-Cap I | |||
JEPSX | 14.54 | 0.04 | +0.28% |
JPMorgan Equity Premium Income R5 | |||
FIJYX | 28.71 | -0.15 | -0.52% |
Fidelity Advisor Biotechnology Z |